We are live on ! Find out more
TCM

Triumph Capital Management Portfolio holdings

AUM $552M
1-Year Est. Return 20.75%
This Fund
S&P 500
This Quarter Est. Return
-2.62%
1 Year Est. Return
+20.75%
3 Year Est. Return
+48.64%
5 Year Est. Return
+27.72%
10 Year Est. Return
AUM
$491M
AUM Growth
+$28.4M
Cap. Flow
+$37.8M
Cap. Flow %
7.7%
Top 10 Hldgs %
19.38%
Holding
1,905
New
135
Increased
641
Reduced
364
Closed
70
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHRW icon
1476
C.H. Robinson
CHRW
$17.5B
$2.83K ﹤0.01%
+17
New +$3.04K
TFSL icon
1477
TFS Financial
TFSL
$4.93B
$2.81K ﹤0.01%
200
-300
-60% -$4.24K
RWT
1478
Redwood Trust
RWT
$594M
$2.81K ﹤0.01%
500
TMC icon
1479
TMC The Metals Company
TMC
$1.98B
$2.8K ﹤0.01%
+600
New +$3.87K
SWK icon
1480
Stanley Black & Decker
SWK
$15.7B
$2.77K ﹤0.01%
39
NJR icon
1481
New Jersey Resources
NJR
$5.58B
$2.77K ﹤0.01%
+50
New +$2.58K
WCN
1482
Waste Connections
WCN
$42B
$2.76K ﹤0.01%
17
AIR icon
1483
AAR Corp
AIR
$5.76B
$2.74K ﹤0.01%
+25
New +$2.69K
SIMS icon
1484
State Street SPDR S&P Kensho Intelligent Structures ETF
SIMS
$8.78M
$2.73K ﹤0.01%
65
RSSB icon
1485
Return Stacked Global Stocks & Bonds ETF
RSSB
$528M
$2.72K ﹤0.01%
100
HSY icon
1486
Hershey
HSY
$36.6B
$2.7K ﹤0.01%
13
+7
+117% +$1.48K
RCS
1487
PIMCO Strategic Income Fund
RCS
$250M
$2.7K ﹤0.01%
500
RMD icon
1488
ResMed
RMD
$30.7B
$2.69K ﹤0.01%
12
+8
+200% +$1.99K
PBE icon
1489
Invesco Biotechnology & Genome ETF
PBE
$292M
$2.69K ﹤0.01%
34
IHI icon
1490
iShares US Medical Devices ETF
IHI
$3.38B
$2.67K ﹤0.01%
50
-210
-81% -$12.3K
SOLS
1491
Solstice Advanced Materials
SOLS
$9.68B
$2.67K ﹤0.01%
35
POWR
1492
iShares U.S. Power Infrastructure ETF
POWR
$458M
$2.62K ﹤0.01%
+100
New +$2.54K
CHD icon
1493
Church & Dwight Co
CHD
$24.5B
$2.61K ﹤0.01%
28
+15
+115% +$1.44K
HOOD icon
1494
Robinhood
HOOD
$83.9B
$2.56K ﹤0.01%
37
+4
+12% +$351
KGC icon
1495
Kinross Gold
KGC
$32.8B
$2.56K ﹤0.01%
84
-11,576
-99% -$379K
PCAR icon
1496
PACCAR
PCAR
$70.1B
$2.54K ﹤0.01%
22
+9
+69% +$1.09K
XAR icon
1497
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.49B
$2.54K ﹤0.01%
10
-5
-33% -$1.37K
NWBI icon
1498
Northwest Bancshares
NWBI
$2.28B
$2.54K ﹤0.01%
200
MCHP icon
1499
Microchip Technology
MCHP
$46B
$2.52K ﹤0.01%
39
-154
-80% -$11.1K
GECC icon
1500
Great Elm Capital Corp
GECC
$81.7M
$2.5K ﹤0.01%
500

Similar funds

Triumph Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Triumph Capital Management held 1,905 positions worth $491M, up 6.1% from $463M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Triumph Capital Management deployed $37.8M of net new capital in Q1 2026, opening 135 new positions and adding to 641 existing holdings. Its largest new stake was Neuberger Short Duration Income ETF: 16,977 shares worth $861K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was First Trust Morningstar Dividend Leaders Index Fund, an estimated $5.53M trimmed.

  • Triumph Capital Management's largest Q1 2026 buy was Neuberger Short Duration Income ETF: 16,977 shares worth $861K.
  • Triumph Capital Management added most to iShares Broad USD Investment Grade Corporate Bond ETF in Q1 2026, an estimated $5.9M increase.
  • Triumph Capital Management's biggest Q1 2026 reduction was First Trust Morningstar Dividend Leaders Index Fund, cutting an estimated $5.53M.
  • Triumph Capital Management fully exited NEOS Enhanced Income Credit Select ETF in Q1 2026, selling an estimated $811K.
  • Triumph Capital Management's ten largest holdings make up 19% of its $491M portfolio in Q1 2026.
  • Triumph Capital Management opened 135 new positions and closed 70 in Q1 2026.
  • Triumph Capital Management's portfolio value rose 6.1% quarter-over-quarter to $491M.

Based on Triumph Capital Management's 13F filing for Q1 2026, filed 13 May 2026.